Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

10.1038/79758 ◽  
2000 ◽  
Vol 1 (4) ◽  
pp. 311-316 ◽  
Author(s):  
Anja Langenkamp ◽  
Mara Messi ◽  
Antonio Lanzavecchia ◽  
Federica Sallusto
2008 ◽  
Vol 180 (6) ◽  
pp. 3782-3788 ◽  
Author(s):  
Chiara Casati ◽  
Chiara Camisaschi ◽  
Luisa Novellino ◽  
Arabella Mazzocchi ◽  
Frédéric Triebel ◽  
...  

Immunity ◽  
2006 ◽  
Vol 24 (5) ◽  
pp. 623-632 ◽  
Author(s):  
Rosa Maria Salazar-Gonzalez ◽  
Jan H. Niess ◽  
David J. Zammit ◽  
Rajesh Ravindran ◽  
Aparna Srinivasan ◽  
...  

Blood ◽  
2011 ◽  
Vol 118 (19) ◽  
pp. 5340-5343 ◽  
Author(s):  
Brian C. Betts ◽  
Erin T. St Angelo ◽  
Michael Kennedy ◽  
James W. Young

Abstract Significant comorbidites and lethality complicate GVHD and its treatment. Targeting the cytokine milieu may improve GVHD control; and IL6 is an attractive candidate, given its role in dendritic cell activation and T-cell differentiation. Tocilizumab is a humanized mAb to IL6-receptor-α (IL6R-α), which is Food and Drug Administration–approved for treatment of rheumatoid arthritis. Mouse transplant models have demonstrated that IL6 blockade also improves GVHD scores and survival. Definitive immunologic effects of IL6 inhibition have not emerged given inconsistent alterations in regulatory T cells (Tregs) and suppression of T-cell proliferation. Despite on-target suppression of IL6R-α signaling in human monocyte-derived dendritic cells (moDCs) and T cells, our data show no effect on moDC maturation/activation, alloreactive T-cell proliferation, Treg expansion, or allogeneic Th1/Th17 responses in vitro. These findings merit attention in any clinical trials of tocilizumab for GVHD prevention or treatment and provide a rationale for evaluating more specific inhibitors of downstream JAK2/STAT3 signaling as well.


2018 ◽  
Vol 50 ◽  
pp. 391-398 ◽  
Author(s):  
Magali Boucher ◽  
Pascale Blais Lecours ◽  
Valérie Létourneau ◽  
Marc Veillette ◽  
Caroline Duchaine ◽  
...  

2006 ◽  
Vol 177 (6) ◽  
pp. 3983-3993 ◽  
Author(s):  
Robert C. Alaniz ◽  
Lisa A. Cummings ◽  
Molly A. Bergman ◽  
Sara L. Rassoulian-Barrett ◽  
Brad T. Cookson

2012 ◽  
Vol 109 (30) ◽  
pp. 12129-12134 ◽  
Author(s):  
Shin-Ichi Inoue ◽  
Mamoru Niikura ◽  
Satoru Takeo ◽  
Shoichiro Mineo ◽  
Yasushi Kawakami ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document